: Intravascular Injection Rates During Cervical Medial Branch Block
NCT ID: NCT05031936
Last Updated: 2022-12-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
67 participants
INTERVENTIONAL
2021-08-12
2022-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Blunt needles with a pencil point tip, such as Whitacre needles, are not as sharp at their tip as are Quincke needles, which have bevels. Toughy or blunt needles may therefore be less likely to penetrate a vessel during a procedure. Hence, we postulated the incidence of intravenous uptake would be significantly lower using a Toughy needle than using a Quincke needle for lumbar medial branch block. To confirm the intravascular injection rates, we used the real time fluoroscopy after injection of contrast medium.
The goal of this study was to compare the incidence of intravascular injection rate betweeen Toughy and Quincke needles using real time fluoroscopy during cervical medial branch block
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Touhy needle group
cervical medial branch block using touhy needle
cervical spinal injection with 0.2% ropivacaine
spinal injections performed in cervical pillar area to relieve chronic neck pain
Quincke needle group
cervical medial branch block using quincke needle
cervical spinal injection with 0.2% ropivacaine
spinal injections performed in cervical pillar area to relieve chronic neck pain
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cervical spinal injection with 0.2% ropivacaine
spinal injections performed in cervical pillar area to relieve chronic neck pain
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pregnancy
* spine deformity
* neurologic abnormality
20 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Keimyung University Dongsan Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ji Hee Hong
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ji Hee Hong
Role: PRINCIPAL_INVESTIGATOR
Keimyung University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hong ji HEE
Daegu, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-07-014
Identifier Type: -
Identifier Source: org_study_id